29 Aug 2025
// BIOSPACE
29 Aug 2025
// FIERCE PHARMA
29 Aug 2025
// ACCESSWIRE
Data Compilation
#PharmaFlow
Latest Content by PharmaCompass
01 6Jetpharma SA
01 1No Action Indicated
02 2No Action Indicated
03 3Voluntary Action Indicated
01 12023-06-23
02 12020-02-07
03 12017-12-01
04 12016-01-29
05 12013-05-08
06 12011-02-16
01 6Balerna
01 6Switzerland
District Decision : No Action Indicated
Inspection End Date : 2023-06-23
City : Balerna
State :
Country/Area : Switzerland
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2023-06-23
District Decision : Voluntary Action Indicated
Inspection End Date : 2020-02-07
City : Balerna
State :
Country/Area : Switzerland
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2020-02-07
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-12-01
City : Balerna
State :
Country/Area : Switzerland
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-12-01
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-01-29
City : Balerna
State :
Country/Area : Switzerland
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-01-29
District Decision : No Action Indicated
Inspection End Date : 2013-05-08
City : Balerna
State :
Country/Area : Switzerland
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2013-05-08
District Decision : No Action Indicated
Inspection End Date : 2011-02-16
City : Balerna
State :
Country/Area : Switzerland
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2011-02-16
Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.